Latest Psoriasis Stories
PETACH TIKVA, Israel, May 29, 2015 /PRNewswire/ -- Can-Fite BioPharma Ltd.
ATLANTA, May 6, 2015 /PRNewswire-USNewswire/ -- Earlier this evening, David A.
-- Results of the VISUAL-I study show HUMIRA meets primary endpoint of prolonging time to treatment failure in patients with non?infectious intermediate, posterior, or panuveitis NORTH CHICAGO,
Novel anti-inflammatory mechanism of action controls secretion of IL-23 PORTOLA VALLEY, Calif., May 4, 2015 /PRNewswire/ -- Rogne Bioscience, a privately-held biotechnology
San Francisco Salt Company will be sponsoring several National Psoriasis Foundation events this year and sharing information about Dead Sea Salt as a natural alternative to treating psoriasis.
INDIANAPOLIS, April 20, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the investigational medicine ixekizumab was statistically superior to placebo in the treatment
Genetic Validation Links Incidence of Generalized Pustular Psoriasis With Abnormal IL-36 Receptor Signal Transduction SAN DIEGO, April 16, 2015 /PRNewswire/ -- AnaptysBio, Inc., a
The Study did not achieve its primary efficacy endpoint PETACH TIKVA, Israel, March 30, 2015 /PRNewswire/ -- Can-Fite
Legislation would lower out-of-pocket drug costs for Americans with chronic diseases PORTLAND, Ore., March 26, 2015 /PRNewswire-USNewswire/ -- Americans with chronic diseases like
- New data at AAD shows 7 out of 10 psoriasis patients who were PASI 75 responders at 52 weeks achieved clear to almost clear skin (PASI 90) after two years of Cosentyx 300 mg treatment
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.